Slow Release DHEA

DRUG2 trials

Sponsors

Indiana University

Conditions

AsthmaGenotype

Phase 1

Evaluate Pharmacokinetics and Safety of Slow Release DHEA

CompletedNCT05623059

Indiana UniversityAsthma, Genotype

Start: 2023-03-03End: 2025-04-24Updated: 2026-09-02

Phase 2

Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )

Not yet recruitingNCT07179952

Indiana UniversityAsthma

Start: 2027-01-01End: 2028-09-30Target: 30Updated: 2026-02-27